AIDS Activists Protest in GlaxoSmithKline Office
MANHATTAN, NY-AIDS activists from several organizations took over the investor relations office of GlaxoSmithKline Monday, demanding changes in the company's policy of donating drugs to Africa.
People from ACT UP New York, ACT UP Philadelphia, and the Health GAP Coalition worked their way into the office and threw "blood money" and empty pill bottles, while chanting "GlaxoSmithKline! GlobalSerialKiller!" They chained themselves together before there were six arrests.
The major demands of the groups focused on the pharmaceutical giant's lack of initiative to help AIDS patients in sub-Saharan Africa, where more than 35 million people are infected with the virus. Specifically they want: GlaxoSmithKline to drop a lawsuit against the South African government that would allow African officials to obtain inexpensive AIDS drugs to treat its citizens; the pharmaceutical giant to drop any legal action against Cipla Pharmaceuticals, an Indian company that provides generic forms of Glaxo's drugs to African countries; and more drug discounts to African countries.
The activists say more than one million people are dying of AIDS around the world every four months.
Information from www.hivandhepatitis.com
The Leapfrog Group and the Positive Effect on Hospital Hand Hygiene
November 21st 2024The Leapfrog Group enhances hospital safety by publicizing hand hygiene performance, improving patient safety outcomes, and significantly reducing health care-associated infections through transparent standards and monitoring initiatives.
Managing Multimorbidity and Polypharmacy in HIV: Insights From Michelle S. Cespedes, MD, MS
November 20th 2024Michelle S. Cespedes, MD, MS, discusses the challenges of managing multimorbidity and polypharmacy in HIV treatment, emphasizing patient education, evolving guidelines, and real-world insights from the REPRIEVE study.
Longhorn Vaccines and Diagnostics to Showcase Breakthrough Vaccine Data at IDWeek 2024
November 19th 2024Longhorn Vaccines and Diagnostics revealed promising data on universal influenza vaccine LHNVD-110 and AMR sepsis vaccine LHNVD-303 at IDWeek 2024, addressing critical global health challenges.
Infection Intel: Revolutionizing Ultrasound Probe Disinfection With Germitec's Chronos
November 19th 2024Learn how Germitec’s Chronos uses patented UV-C technology for high-level disinfection of ultrasound probes in 90 seconds, enhancing infection control, patient safety, and environmental sustainability.
CDC HICPAC Considers New Airborne Pathogen Guidelines Amid Growing Concerns
November 18th 2024The CDC HICPAC discussed updates to airborne pathogen guidelines, emphasizing the need for masks in health care. Despite risks, the committee resisted universal masking, highlighting other mitigation strategies
